Practice guidelines for pharmacists

Abstract

Get full access to this article

View all access options for this article.

References

Bykerk

Akhavan

Hazlewood

. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. J Rheumatol 2012;39:1559-82.

Soubrier

Mathieu

Payet

. Elderly-onset rheumatoid arthritis. Joint Bone Spine 2010;77:290-6.

Bombardier

Hazlewood

Akhavan

. Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety. J Rheumatol 2012;39:1583-602.

Moeez

John

Bhatti

. Anti-citrullinated protein antibodies: role in pathogenesis of RA and potential as a diagnostic tool. Rheumatol Int 2013;33:1669-73.

Conaghan

. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy and toxicity. Rheumatol Int 2012;32:1491-502.

Rainsford

Bjarnason

. NSAIDs: take with food or after fasting? J Pharm Pharmacol 2012;64:465-9.

Bjarnason

. Gastrointestinal safety of NSAIDs and over the counter analgesics. Int J Clin Pract 2013;67(Suppl 178):37-42.

Day

. Non-steroidal anti-inflammatory drugs (NSAIDs). BMJ 2013;346:f3195.

Wallace

. Polypharmacy of osteoarthritis: the perfect intestinal storm. Dig Dis Sci 2013;58:3088-93.

10.

Soubrier

Rosenbaum

Tatar

. Vascular effects of nonsteroidal antiinflammatory drugs. Joint Bone Spine 2013;80:358-62.

11.

Flynn

Bakris

. Role of ambulatory blood pressure monitoring in hypertension and diabetes. Curr Hypertens Rep 2013;15:137-42.

12.

Scott

Wolfe

Huizinga

. Rheumatoid arthritis. Lancet 2010;376:1094-108.

13.

e-CPS. Corticosteroids: systemic. Available: www.e-cps.ca (by subscription only) (accessed Sep. 25, 2013).

14.

Habib

Miari

. The effect of intra-articular triamcinolone preparation on blood glucose levels in diabetic patients. J Clin Rheumatol 2011;17:302-5.

15.

Dahl

Hammert

. Overview of injectable corticosteroids. J Hand Surg Am 2012;37:1715-7.

16.

Kaltsonoudis

Papagoras

Drosos

. Current and future role of methotrexate in the therapeutic armamentarium for rheumatoid arthritis. Int J Clin Rheumatol 2012;7:179-89.

17.

Katchamart

Bourré-Tessier

Donka

. Canadian recommendations for the use of methotrexate in patients with rheumatoid arthritis. J Rheumatol 2010;37:1422-30.

18.

Colebatch

Marks

van der Heijde

Edwards

. Safety of nonsteroidal anti-inflammatory drugs and/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic review. J Rheumatol 2012;90:62-73.

19.

Al-Quteimat

Al-Badaineh

. Methotrexate and trimethoprim-sulphamethoxazole: extremely serious and life-threatening combination. J Clin Pharm Ther 2013;38:203-5.

20.

Ruderman

. Overview of safety of non-biologics and biologic DMARDs. Rheumatology 2012;51:37-43.

21.

Colburn

. Disease-modifying antirheumatic drugs. Rev Rheumatol 2012;20:507-32.

22.

e-Therapeutics. Therapeutic choices. Available: www.e-therapeutics.ca (by subscription only) (accessed Dec. 27, 2013).

23.

Rajakulendran

Gadsby

Deighton

. Rheumatoid arthritis, alcohol, leflunomide and methotrexate: can changes to the BSR guidelines for leflunomide and methotrexate on alcohol consumption be justified? Musculoskelet Care 2008;6:233-45.

24.

Dogra

Mahejan

. Systemic methotrexate therapy for psoriasis: past, present and future. Clin Exp Derm 2013;38:573-88.

25.

Tilling

Townsend

David

. Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis. Clin Drug Invest 2006;26:55-62.

26.

Bird

Griffiths

Tymms

. The SMILE study: safety of methotrexate in combination with leflunomide in rheumatoid arthritis. J Rheumatol 2013;40:228-35.

27.

Teschke

Schwarzenboeck

Eickhoff

. Clinical and causality assessment in herbal hepatotoxicity. Expert Opin Drug Saf 2013;12:339-66.

28.

O’Dell

Mikuls

Taylor

. Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med 2013;369:307-18.

29.

Isik

Halacli

Atmaca

. Triple DMARD combination for rheumatoid arthritis resistant to methotrexate and steroid combination: a single-centre experience. Rheumatol Int 2013;33:1425-7.

30.

DeJong

. Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the REACH trial. Ann Rheum Dis 2013;72:72-8.

31.

Harris

Bykerk

Hitchon

. Determining best practices in early rheumatoid arthritis by comparing differences in treatment at sites in the Canadian Early Arthritis Cohort. J Rheumatol 2013;40:1823-30.

32.

Saag

Teng

Patkar

. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762-84.

33.

Singh

Furst

Bharat

. 2012 update of the 2008 recommendations for the use of disease-modifying antirheumatic drugs and biologics in the treatment of rheumatoid arthritis. Arthritis Care Res 2012;64:625-39.

34.

Sanofi. Plaquenil (product monograph). Available: http://products.sanofi.ca/en/plaquenil.pdf (accessed Sep. 1, 2013).

35.

Marmor

Kellner

Lai

. American Academy of Ophthalmology update: revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 2011;118:415-22.

36.

El-Tawil

Al Musa

Valli

. Quinine for muscle cramps. Cochrane Database Syst Rev 2010;(12):CD005044.

37.

Brasic

. Quinine-induced thrombocytopenia in a 64 year old man who consumed tonic water to relieve nocturnal leg cramps. Mayo Clin Proc 2001;76:863-4.

38.

Wielgus

Chignell

Miller

. Phototoxicity in human retinal pigment epithelial cells promoted by hypericin, a component of St John’s Wort. Photochem Photobiol 2007;83:706-13.

39.

Cansu

Korkmaz

. Hypoglycemia induced by hydroxychloroquine in a non-diabetic patient treated for RA. Rheumatology 2008;47:379-80.

40.

Lee

Silverman

Bargman

. The role of antimalarial agents in the treatment of SLE and lupus nephritis. Nat Rev Nephrol 2011;7:718-29.

41.

Kim

Östör

Nisar

. Interleukin-6 and cytochrome-P450, reason for concern? Rheumatol Int 2012;32:2601-4.

42.

Al-Shakarchi

Gullick

Scott

. Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a review. Patient Prefer Adherence 2013;7:653-66.